Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ofer Agid

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 18, 2021
Real-World Utilization Patterns of Long-Acting Injectable Antipsychotics in Canada: A Retrospective StudyOfer Agid, Gary Remington, Carmen Fung, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 18, 2015
What does schizophrenia teach us about antipsychotics?Gary Remington, Ofer Agid, George Foussias, et al.
JAMA Psychiatry|July 31, 2014
Motivational deficits and cognitive test performance in schizophreniaGagan Fervaha, Konstantine K Zakzanis, George Foussias, et al.
Journal of Psychopharmacology (Oxford, England)|January 31, 2025
Challenges for switching central nervous system and psychiatric medication products: A review of the literatureRic M Procyshyn, Martin A Katzman, Howard C Margolese, et al.
The Journal of Clinical Psychiatry|April 5, 2011
An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysisOfer Agid, Tamara Arenovich, Gautam Sajeev, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 6, 2018
Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. second-episode schizophreniaHiroyoshi Takeuchi, Cynthia Siu, Gary Remington, et al.
Comprehensive Psychiatry|December 16, 2017
Investigating the predictors of happiness, life satisfaction and success in schizophreniaSarah Saperia, Susana Da Silva, Ishraq Siddiqui, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 9, 2015
Antipsychotics and amotivationGagan Fervaha, Hiroyoshi Takeuchi, Jimmy Lee, et al.
Journal of Psychiatric Research|August 25, 2009
Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remissionTerence A Ketter, Ofer Agid, Shitij Kapur, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 28, 2013
Antipsychotic response in first-episode schizophrenia: efficacy of high doses and switchingOfer Agid, Laura Schulze, Tamara Arenovich, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 18, 2021
Real-World Utilization Patterns of Long-Acting Injectable Antipsychotics in Canada: A Retrospective StudyOfer Agid, Gary Remington, Carmen Fung, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 18, 2015
What does schizophrenia teach us about antipsychotics?Gary Remington, Ofer Agid, George Foussias, et al.
JAMA Psychiatry|July 31, 2014
Motivational deficits and cognitive test performance in schizophreniaGagan Fervaha, Konstantine K Zakzanis, George Foussias, et al.
Journal of Psychopharmacology (Oxford, England)|January 31, 2025
Challenges for switching central nervous system and psychiatric medication products: A review of the literatureRic M Procyshyn, Martin A Katzman, Howard C Margolese, et al.
The Journal of Clinical Psychiatry|April 5, 2011
An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysisOfer Agid, Tamara Arenovich, Gautam Sajeev, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 6, 2018
Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. second-episode schizophreniaHiroyoshi Takeuchi, Cynthia Siu, Gary Remington, et al.
Comprehensive Psychiatry|December 16, 2017
Investigating the predictors of happiness, life satisfaction and success in schizophreniaSarah Saperia, Susana Da Silva, Ishraq Siddiqui, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 9, 2015
Antipsychotics and amotivationGagan Fervaha, Hiroyoshi Takeuchi, Jimmy Lee, et al.
Journal of Psychiatric Research|August 25, 2009
Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remissionTerence A Ketter, Ofer Agid, Shitij Kapur, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 28, 2013
Antipsychotic response in first-episode schizophrenia: efficacy of high doses and switchingOfer Agid, Laura Schulze, Tamara Arenovich, et al.
Pageof 13